Stiff person syndrome (SPS) is a rare autoimmune neurological disorder that causes muscle stiffness in the torso, arms, and legs, which can make movement difficult. Around 80% of patients experience significant loss of mobility, often requiring walking aids or a wheelchair, and the condition carries a risk of permanent disability and increased mortality.
Currently, there are no therapies specifically approved by the FDA for SPS, and so treatment focuses on managing symptoms and improving quality of life. This typically involves a combination of medications to reduce stiffness and spasms, immunotherapies to address the underlying autoimmune process, and supportive care such as physical and occupational therapy to maintain function and independence.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.